30/08/2015 15:59:37 Free Membership Login

Accentia Biopharmaceuticals, (PN News (USOTC:ABPI)

DateTimeSource
Headline
10/16/20147:00AMIHNWNew Technologies in the Medical Market Space and Today’s Bounce Alert is Everlet, Inc.
Burton, MI - October 16, 2014 - InvestorsHub NewsWire - Accentia Biopharmaceuticals, Inc. (OTCBB: ABPI) is engaged in the business of commercializing patent-protected disruptive healthcare technologies designed to be positioned as leading products for the treatment of a broad range of chronic, debilitating and life-threatening... More...>>
08/06/20135:26PMPRNUSSHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Accentia Biopharmaceuticals, Inc. and Certain Officer...
SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Accentia Biopharmaceuticals, Inc. and Certain Officers and Biovest International, Inc. - ABPI and BVTI PR Newswire NEW YORK, Aug. 6, 2013 NEW YORK, Aug. 6, 2013 /PRNewswire/ -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class... More...>>
07/31/201312:07PMPRNUSShareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Accenti...
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces that a Securities Class Action has been Filed Against Accentia Biopharmaceuticals, Inc. and Officers of Accentia and Biovest International, Inc. PR Newswire NEW YORK, July 31, 2013 NEW YORK, July 31, 2013 /PRNewswire/ -- Attorney Advertising --  Bronstein... More...>>
07/30/20136:35PMBWShapiro Haber & Urmy LLP & Liggio Benrubi PA Announce the Filing of a Class Action Lawsuit Against Accentia Biopharmaceutical...
Shapiro Haber & Urmy LLP and Liggio Benrubi PA filed a class action on July 26, 2013 against Accentia Biopharmaceuticals, Inc. (“Accentia”) (ABPI) and certain officers and directors of Accentia and Biovest International, Inc. (“Biovest”) (OTCQB:BVTI), a majority-owned subsidiary of Accentia, for violations of federal... More...>>
07/30/20136:35PMBWShapiro Haber & Urmy LLP & Liggio Benrubi PA Announce the Filing of a Class Action Lawsuit Against Accentia Biopharmaceutical...
Shapiro Haber & Urmy LLP and Liggio Benrubi PA filed a class action on July 26, 2013 against Accentia Biopharmaceuticals, Inc. (“Accentia”) (ABPI) and certain officers and directors of Accentia and Biovest International, Inc. (“Biovest”) (OTCQB:BVTI), a majority-owned subsidiary of Accentia, for violations... More...>>
03/07/20134:45PMBWBiovest Files Recapitalization Plan to Strengthen Balance Sheet & Advance Commercialization Strategy for BiovaxID™ Cancer V...
Biovest International, Inc. (OTCQB:BVTI) today reported that the Company has filed a petition for protection under Chapter 11 of the U.S. Bankruptcy Code and a Plan of Reorganization (the “Plan”) seeking to implement a restructuring of its balance sheet that would eliminate approximately $44 million in senior secured... More...>>
12/04/20122:45PMBWBiovest to Present BiovaxID™ Cancer Vaccine Update at Lymphoma Coalition Patient Advocacy Event prior to ASH Meeting
Biovest International, Inc. (OTCQB: “BVTI”), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: “ABPI”), today announced that Biovest will present at the Lymphoma Coalition’s annual patient advocacy event leading up to the American Society of Hematology (ASH) Annual Meeting in Atlanta, Dec... More...>>
09/20/20128:15AMBWBiovest Conducts Meeting with EMA Advancing Process to Seek EU Approval for Cancer Vaccine
Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today reported milestone achievements advancing BiovaxID™, Biovest’s personalized cancer vaccine for the treatment of non-Hodgkin’s lymphoma, including a recently conducted regulatory meeting... More...>>
09/11/20127:45AMBWBiovest Names Lymphoma Key Opinion Leader from MD Anderson Cancer Center to Scientific Advisory Board
Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that it appointed Sattva S. Neelapu, M.D., Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center to Biovest’s... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq abpi150830 15:59